Immobilization hypercalcemia in critical illness following bariatric surgery.
BACKGROUND
Immobilization hypercalcemia has been previously reported in a number of entities but not as a complication of bariatric surgery. We recognized this complication in two consecutive bariatric patients requiring intensive care unit (ICU) admission.


METHODS
These two patients are reported in detail, and a review of our ICU database is also reported.


RESULTS
Treatment of immobilization hypercalcemia in these two patients with pamidronate was successful.


CONCLUSIONS
Immobilization hypercalcemia complicating the course of bariatric patients requiring ICU admission is a newly recognized and treatable entity.
Alborzi
Farzin
F
Mount Sinai School of Medicine, Division of Surgical Critical Care, Department of Surgery and Anesthesiology, New York, NY 10029, USA.
Leibowitz
Andrew B
AB
D000328:Adult; D004164:Diphosphonates / Q000627:therapeutic use*; D015391:Gastroplasty; D006801:Humans; D006934:Hypercalcemia / Q000097:blood / Q000209:etiology*; D007103:Immobilization / Q000009:adverse effects*; D008297:Male; D000077268:Pamidronate; D010281:Parathyroid Hormone / Q000097:blood; D011183:Postoperative Complications; D012189:Retrospective Studies
D004164:Diphosphonates; D010281:Parathyroid Hormone; D000077268:Pamidronate